About this Session:
National drug spending is expected to reach $863 billion by 2028 due to new, higher priced drugs entering the market more frequently. How can we prevent patients in need from being priced out of the market? In efforts to reduce out-of-pocket costs, some pharmacy leaders have implemented outcome-based contracts while others have bypassed the supply chain middlemen entirely. The methods may differ, but the goal is clear: increase access, affordability and adherence.